Recipharm completes Korean serialisation project for Abbott

Recipharm applied its solution, designed to achieve full compliance with country-specific regulations, to a blister packaging line. Validation batches are now manufactured released and planned to be shipped to Korea beginning in mid-March. Though similar to the EU, the company said the Korean serialisation differed markedly from what’s expected in China.
From the outset, integration formed a key tenet in the collaboration between the two companies, with the establishment of joint company strategic teams and the sharing of critical information, Recipharm said.   

A company spokesman also told us: "Except from the projects for China and Korea, Recipharm is working on a Group wide project to be able to meet the EU rules.​" 

Stephane Guisado, General Manager at Recipharm in Fontaine added: “Once again, our serialisation platform solution has proved the extent of its adaptability and resourcefulness for differing geographic and multi-country regulatory requirements. Indeed, in this case, it ensured that our customer complied in full with the relevant serialisation regulations set down by Korea​.”